A Case of Sub-Diaphragmatic Abscess after Injection of Botulinum Toxin to Treat Achalasia
Author(s) -
Constantine Fisher,
Frances Puello,
Samson Ferm,
Moshe Rubin,
Alan H. Schnall
Publication year - 2017
Publication title -
acg case reports journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.112
H-Index - 4
ISSN - 2326-3253
DOI - 10.14309/crj.2017.119
Subject(s) - achalasia , medicine , botulinum toxin , esophageal sphincter , adverse effect , abscess , esophagus , esophageal motility disorder , surgery , anesthesia , reflux , disease
Achalasia is a disorder of the esophagus characterized by decreased lower esophageal sphincter (LES) relaxation and absence of esophageal peristalsis. Botulinum toxin (BT) injection targeting the LES has been used in the treatment of achalasia and other esophageal motility disorders, and it is considered to be safe and effective for short-term symptomatic relief. Serious adverse events of this procedure are rare. We report the case of an 83-year-old woman treated with BT injection for achalasia who subsequently developed a subdiaphragmatic abscess.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom